BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19524489)

  • 1. Upregulated BclG(L) expression enhances apoptosis of peripheral blood CD4+ T lymphocytes in patients with systemic lupus erythematosus.
    Luo N; Wu Y; Chen Y; Yang Z; Guo S; Fei L; Zhou D; Yang C; Wu S; Ni B; Hao F; Wu Y
    Clin Immunol; 2009 Sep; 132(3):349-61. PubMed ID: 19524489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus.
    Deng YJ; Huang ZX; Zhou CJ; Wang JW; You Y; Song ZQ; Xiang MM; Zhong BY; Hao F
    Mol Immunol; 2006 Mar; 43(9):1497-507. PubMed ID: 16143398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
    Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
    Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal differentiation of memory T cells in systemic lupus erythematosus.
    Fritsch RD; Shen X; Illei GG; Yarboro CH; Prussin C; Hathcock KS; Hodes RJ; Lipsky PE
    Arthritis Rheum; 2006 Jul; 54(7):2184-97. PubMed ID: 16802356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM; Taher TE; Isenberg DA; Mageed RA
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD45 isoforms expression on CD4+ and CD8+ peripheral blood T-lymphocytes is related to auto-immune processes and hematological manifestations in systemic lupus erythematosus.
    Neidhart M; Pataki F; Michel BA; Fehr K
    Schweiz Med Wochenschr; 1996 Nov; 126(45):1922-5. PubMed ID: 8946597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
    Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells.
    Peng S; Lalani S; Leavenworth JW; Ho IC; Pauza ME
    Eur J Immunol; 2007 Oct; 37(10):2868-80. PubMed ID: 17823980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
    Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
    Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
    J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related susceptibility of naive and memory CD4 T cells to apoptosis induced by IL-2 deprivation or PHA addition.
    Donnini A; Re F; Bollettini M; Moresi R; Tesei S; Bernardini G; Provinciali M
    Biogerontology; 2005; 6(3):193-204. PubMed ID: 16041623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
    Fournel S; Muller S
    Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients.
    Beşliu AN; Pistol G; Marica CM; Bănică LM; Chiţonu C; Ionescu R; Tănăseanu C; Tamsulea I; Matache C; Stefănescu M
    Roum Arch Microbiol Immunol; 2009; 68(2):69-79. PubMed ID: 20361524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H
    Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus.
    Graninger WB; Steiner CW; Graninger MT; Aringer M; Smolen JS
    Cell Death Differ; 2000 Oct; 7(10):966-72. PubMed ID: 11279543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.